Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > ViaCyte

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Sep 08, 2022 2:21pm

178 Views

Post# 34950079

RE:RE:ViaCyte

So more of the same from Spilly. Nothing new, just wait wait wait. While we sit here and wait, the others keep pulling ahead. This play isn't doing anything for years. They'll run out of money and we will be complaining about the next shi*ty placement. Was a great idea/product but ruined by incompetent management. Did anyone here learn anything new? I sure as heck didn't other than things are going to take longer than I hoped they would.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China